Clinical trial
Neoadjuvant Immunotherapy in Advanced NSCLC
NCT05137912 is registered in ClinicalTrials.gov with Power Life Sciences Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neoadjuvant Immunotherapy in Advanced NSCLC
- Lead sponsor
- Power Life Sciences Inc.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 1, 2022
- Completion date
- December 1, 2022
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer, non-small cell